|
|
Vaccine Detail
|
live attenuated Brucella ovis strain delta abcBA vaccine |
| Vaccine Information |
- Vaccine Name: live attenuated Brucella ovis strain delta abcBA vaccine
- Target Pathogen: Brucella spp.
- Target Disease: Brucellosis
- Vaccine Ontology ID: VO_0009328
- Type: Live attenuated vaccine
- Status: Research
- Host Species for Licensed Use: Sheep
- Host Species as Laboratory Animal Model: Mus musculus (BALB/c and C57BL/6 mice)
- Antigen: abcBA deletion mutant
- Preparation: The vaccine was formulated as an encapsulated live attenuated ΔabcBA strain; both single and multiple doses were tested, with encapsulation significantly improving protection. (Silva et al, 2015)
- Description: The study evaluated the Brucella ovis ΔabcBA strain as a vaccine candidate in mice to assess protection against wild-type B. ovis challenge. Efficacy: Single or multiple immunizations with non-encapsulated strain provided mild protection with reduced liver bacterial loads but not spleen; encapsulated vaccine significantly improved protection in both mouse strains and prevented lesions in spleen and liver. (Silva et al, 2015)
|
| Host Response |
|
Mouse Response
- Vaccination Protocol: BALB/c and C57BL/6 mice were immunized subcutaneously or intraperitoneally with single or multiple doses of the vaccine strain. (Silva et al, 2015)
- Challenge Protocol: BALB/c and C57BL/6 mice were immunized subcutaneously or intraperitoneally with single or multiple doses of the vaccine strain, then challenged with wild-type B. ovis; bacterial counts and lesion development in liver and spleen were assessed. (Silva et al, 2015)
- Efficacy: Single or multiple immunizations with non-encapsulated strain provided mild protection with reduced liver bacterial loads but not spleen; encapsulated vaccine significantly improved protection in both mouse strains and prevented lesions in spleen and liver. (Silva et al, 2015)
- Description: BALB/c and C57BL/6 mice were immunized subcutaneously or intraperitoneally with single or multiple doses of the vaccine strain, then challenged with wild-type B. ovis; bacterial counts and lesion development in liver and spleen were assessed. (Silva et al, 2015)
|
| References |
Silva et al, 2015: Silva AP, Macêdo AA, Silva TM, Ximenes LC, Brandão HM, Paixão TA, Santos RL. Protection Provided by an Encapsulated Live Attenuated ΔabcBA Strain of Brucella ovis against Experimental Challenge in a Murine Model. Clinical and vaccine immunology : CVI. 2015 Jul; 22(7); 789-97. [PubMed: 25947146].
|
|